Skip to content

Follow up of Patients After Oral Immunotherapy for Cow's Milk, Eggs and Peanuts

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01999387
Acronym
OIT followup
Enrollment
500
Registered
2013-12-03
Start date
2013-06-30
Completion date
2016-12-31
Last updated
2013-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy

Keywords

food, consumption

Brief summary

Food allergy is a potentially life threatening condition. The current practice consists of elimination diet and injectable epinephrine in case of a reaction. Recently, oral immunotherapy has emerged as a treatment for food allergy in milk eggs and peanuts. We conduct an oral immunotherapy program with \ 500 patients so far. In this study we intent to follow patients who completed the program and assess their allergy status and quality of life.

Detailed description

Food allergy is a potentially life threatening condition. The current practice consists of elimination diet and injectable epinephrine in case of a reaction. Recently, oral immunotherapy (OIT) has emerged as an treatment for food allergy in milk eggs and peanuts. Since 4/2010,a clinical OIT program for milk eggs and peanuts is performed at the Institute fir Allergy Asthma and Immunology at Assaf Harofeh Medical Center with \ 500 patients so far. Patients with IgE-mediated food allergy that are \>4 years old are eligible. In this study we intent to follow patients who completed the program. Patients will fill a questionnaire regarding current consumption of the allergenic food, adverse reactions experienced and treatments required including the use of EpiPen. Patients underwent skim prick tests (SPT) for the allergenic food prior to initiation and treatment and will undergo SPT again upon entering the study. Blood tests for IgE, IGG4, basophil activation and cytokines will be obtained. Patients who are not consuming the allergenic food regularly will undergo an oral food challenge in clinic.

Interventions

DIETARY_SUPPLEMENTAllergenic food

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
4 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* age\>4 years old IgE mediated allergy to milk eggs or peanuts Completion of OIT \>6 months ago

Exclusion criteria

* Non approval to participate

Design outcomes

Primary

MeasureTime frame
Allergenic food consumption questionnaire6 months

Countries

Israel

Contacts

Primary ContactYitzhak Katz, MD
ykatz49@gmail.com97289779820
Backup ContactArnon Elizur
elizura@gmail.com97289779820

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026